External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ACR 2024

We will be contributing to topics related to
-
03:30 PM
Duration 2hrs Washington DC, USA
Understanding the Patient Burden of Lupus: Insights From a Multi-Faceted Ethnography Research
Andersen J, Meyer I, Camadoo N, Machado T, Saraf S, Akrout M
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 2hrs Washington DC, USA
Evaluating the concordance between SRI-4 and BICLA in the EXPLORER and ATHOS trials in active systemic lupus erythematosus
Askanase A, Vital EM, Meier O, Turchetta A, Mao H(A), Maller J, Terres JAR, Dall'Era M
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 2hrs Washington DC, USA
Obinutuzumab Benefits Patients With Active Lupus Nephritis Irrespective of Baseline Proteinuria Severity: a Post Hoc Analysis of a Phase II Trial
Furie RA, Terres JAR, Martins E, Hassan I, Schindler T, Garg J, Pendergraft W, Malvar A, Rovin B
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:30 PM
Duration 2hrs Washington DC, USA
Characteristics and treatment patterns of patients with lupus nephritis: a retrospective claims database study in the USA
Patel A, Xia Z, Lindsay L, Ng C, Pendergraft W, Dall'Era M
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon